New patent for Boehringer Ingelheim drug SYNJARDY XR

Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are six…
The post New patent for Boehringer Ingelheim drug SYNJARDY XR appeared f…


Biotechblog